MMK, Stockholm University
Svante Arrhenius vÃ¤g 16 C
Stockholm 106 91
Industry: Drug Manufacturers—General
Full Time Employees: 1
|Mr. Ola Holmlund||Chief Exec. Officer||439k||N/A||1969|
|Mr. Olle Holmertz||Founder & Bus. Controller||540k||N/A||1963|
|Mr. Anders Carlsson Ph.D.||Co-Founder, Sr. Advisor & Chief Devel. Officer||N/A||N/A||N/A|
|Dr. Bengt HerslÃ¶f||Co-founder & Sr. Scientific Advisor||N/A||N/A||N/A|
|Dr. Jan HolmbÃ¤ck Ph.D.||Co-Founder & Chief Scientific Officer||N/A||N/A||1957|
|Dr. Gerhard Miksche||Co-Founder||N/A||N/A||N/A|
|Mr. Michael Owens B.A., B.S., B.S.B.A||Chief Financial Officer||N/A||N/A||1956|
Lipidor AB (publ), a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, bacterial skin infections, and atopic dermatitis. The company develops AKP-01, which is in Phase III for the treatment of psoriasis; and preclinical stage products, such as AKP-02 for psoriasis, and AKP-03 AKP-07 for eczema. It offers active pharmaceutical ingredients used in products for various therapeutic applications, such as anti-psoriasic, antimicrobial, anti-inflammatory, antifungal, local anesthetics, non-steroidal anti-inflammatory, anti-acne, wound healing, anti-eczema, and anti-migraine. The company also develops a range of spray products for animal skin care in dogs, cats, and horses; and consumer health care products for applications, including antibacterial, antiseptic, moisturizing emollient, disinfectant, and acne and wart treatment. The company has a collaboration agreement with Cannassure Therapeutics Ltd. for the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions. Lipidor AB (publ) was founded in 2009 and is based in Stockholm, Sweden.
Lipidor AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.